Bioceres Crop Solutions Corp. income statement

In fiscal 2026, Bioceres Crop Solutions Corp. reported revenue of $238m, down 17.7% on the year before, operating income of −$23.4m (a -9.8% margin) and net income of −$264m, or −$4.06 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bioceres Crop Solutions Corp.: income statement, annual
Fiscal year	2017Dec 2016	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Revenue	41	134	161	173	210	335	420	420	289	238
Cost of revenue	31	77	87	94	119	208	235	263	184	155
Gross profit	11	56	74	80	91	126	185	157	105	83
Research and development	1	4	4	4	6	7	15	8	9	11
General and administrative	0	1	0	0	1	—	—	—	—	—
Operating income	0	16	32	39	38	40	54	52	7	−23
Income before tax	−8	−25	−9	6	11	14	19	22	−47	−75
Income tax	−2	−11	7	2	14	18	−1	7	3	7
Net income	−6	−11	−18	3	−7	−7	19	4	−55	−264
Diluted EPS	−$0.21	−$0.39	−$0.60	$0.09	−$0.18	−$0.17	$0.30	$0.07	−$0.88	−$4.06
Diluted shares (average)	28m	28m	30m	36m	39m	42m	63m	63m	63m	64m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AVD vs BIOX BIOX vs UAN BIOX vs FMC BIOX vs SEED

More: Fertilizers & Agricultural Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Bioceres Crop Solutions Corp.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bioceres Crop Solutions Corp.